A B O U T U S
Personal is powerful. We engineer bespoke cells, tissues, and organs that resist rejection by the human immune system.
Our therapeutic platform begins with safety. In September 2019, XenoTherapeutics performed the first non-human organ transplant with Xeno-Skin. This proof of concept has established safety via a regulatory pathway and is advancing the future of xenotransplantation. We envision future xeno solutions utilizing immune-compatible, patient-specific cells, tissues, and organs via CRISPR technology.